摘要:
The present invention is directed to a method of reducing the rate of proliferation of adenoma cells which method comprises contacting said pituitary adenoma cells with one or more of an SSTR1 agonist, and/or one or more of an SSTR2 agonist, and/or one or more of SSTR5 agonist, or one or more pharmaceutically acceptable salts thereof, either alone or in combination.
摘要:
Claimed is a somatostatin agonist according to the formula (I): D-Phe-c(Cys-Tyr(I)-D-Trp-Lys-Val-Cys)-Thr-NH2, or a pharmaceutically acceptable salt thereof, and uses thereof.
摘要:
Disclosed is a series of somatostatin-dopamine chimeric analogs which retain both somatostatin and dopamine activity in vivo. An example is : 6-n-propyl-8β-ergolinglmethylthioacetyl-D-Phe-c-(Cys-Tyr-D-Trp-Lys-Abu-Cys)-Thr-NH¿2?